Brain tumour (medulloblastoma)

Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.

Who can joinChildren

Age3–16 years

Kind of studyStudy of how care is given

What it testsRadiation

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Where to go

1 hospital in India taking patients for this trial.

Tata Memorial HospitalMumbai, MaharashtraDirections ↗

Registry summary (technical)

This clinical study is going to be done on a type of brain tumor in children called Medulloblastoma. The WNT pathway type of medulloblastoma is considered to be low risk and have the best outcomes in terms of survival. With the current standard of care for this type of medulloblastoma it is believed by the investigators that we are over treating the disease and increasing the long term side effects of these children. Several groups in the world are testing de-intensification of treatment in this favourable subset of children who experience long term late side effects of therapy. By reducing th…

Sponsor: Tata Memorial Centre
NCT04474964 on ClinicalTrials.gov
Last updated on the registry 9 Apr 2025 · read by us 20 Oct 2026

Brain tumour (medulloblastoma)

Where to go

Need help reaching the trial team? Write to us.